LCN2 and diabetic kidney disease: Additionally, there was a negative correlation between the serum levels of neutrophil gelatinase-associated lipocalin (NGAL), an indicator of diabetic nephropathy, and the serum levels of Sestrin2 in diabetic patients [10].